CD20-negative relapse after 131I-anti-CD20 therapy [5]

Journal of Clinical Oncology

Volumn 17, Issue 11, 1999, Pages 3692-3693

  Venugopal, P ^a   Leslie, W T ^a   O'Brien, T ^a   Gregory, S A ^a  

^a RUSH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY I 131; TOSITUMOMAB I 131; UNCLASSIFIED DRUG;

AGED; B CELL LYMPHOMA; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CASE REPORT; FEMALE; HUMAN; LARGE CELL LYMPHOMA; LETTER; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; TREATMENT OUTCOME;

EID: 0032745011     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1999.17.11.3692     Document Type: Letter

References (4)